Thinking, writing, training

Telephone Number: +44 (0)1235 760 645

Envestia is a small, highly-skilled specialist consultancy, established in 2007, offering regulatory and clinical development support to the pharmaceutical and medical device industries.

Copyright © All Rights Reserved 2015 | Built by Paul Kemp

Steve Pinder:

+44 (0)1844 210 690

Ian Dews:

+44 (0)1235 760 645


Contact Details



Steve Pinder


You are here:

Steve qualified in biochemistry before completing a PhD and post-doctoral work in molecular genetics.

He began his regulatory career with Smith & Nephew before moving to Chauvin Pharmaceuticals where he managed clinical research and drug safety functions in addition to the regulatory team.

In 1998 Steve joined Phoenix International to lead and develop the European regulatory group.

He went on to become Global Head of Regulatory Affairs and Drug Safety for MDS Pharma Services.

Steve’s regulatory expertise is focused on the clinical area, most notably in scientific advice, orphan drugs, paediatric investigation plans, development planning, elaboration of regulatory strategy and preparation of clinical overviews and summaries.

He is a regular trainer on clinical development topics for TOPRA and has also presented at numerous other symposia in Europe, US and Japan.